
ScienceMore in Science→
FDA Clears First Gene Therapy for an Inherited Form of Deafness
The U.S. FDA has approved Regeneron’s Otarmeni, the first gene therapy cleared for hearing loss caused by OTOF mutations, marking a major milestone for genetic medicine and auditory research.
Key Takeaways
- The FDA approved Otarmeni for hearing loss caused by OTOF mutations.
- It is the first gene therapy cleared for inherited deafness.
DE
DT Editorial Team··via livescience.com